9 Meters Biopharma, Inc. NMTRQ
At closeNov 9, 2026, 4:00 PM EST
- YTD
- 0.00%
- 1 year
- 0.00%
NMTRQ free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-37,246,059 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | -37,246,059 | -7,755,308 | Not meaningful |
| FY 2021 | 2021-12-31 | -29,490,751 | -10,078,422 | Not meaningful |
| FY 2020 | 2020-12-31 | -19,412,329 | -1,432,403 | Not meaningful |
| FY 2019 | 2019-12-31 | -17,979,926 | -2,796,653 | Not meaningful |
| FY 2018 | 2018-12-31 | -15,183,273 | -10,048,000 | Not meaningful |
| FY 2017 | 2017-12-31 | -5,135,273 | 3,291,727 | Not meaningful |
| FY 2016 | 2016-12-31 | -8,427,000 | -6,697,000 | Not meaningful |
| FY 2015 | 2015-12-31 | -1,730,000 | 5,722,000 | Not meaningful |
| FY 2014 | 2014-12-31 | -7,452,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:13.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.